Can you provide the average price target for ALSTOM stock?
22 analysts have analysed AOMD.DE and the average price target is 26.51 EUR. This implies a price increase of 13.89% is expected in the next year compared to the current price of 23.28.
FRA:AOMD • FR0010220475
View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for ALSTOM (AOMD.DE).
| Date | Firm | Action | From → To |
|---|---|---|---|
| 2021-07-22 | UBS | Initiate | |
| 2021-07-21 | UBS | Initiate | |
| 2021-07-20 | JPMorgan Chase | Initiate | |
| 2021-07-20 | Goldman Sachs | Initiate | |
| 2021-07-20 | Jefferies | Initiate | |
| 2021-07-16 | UBS | Initiate | |
| 2021-07-15 | UBS | Initiate | |
| 2021-07-13 | JPMorgan Chase | Initiate | |
| 2021-07-13 | Goldman Sachs | Initiate | |
| 2021-07-07 | UBS | Initiate | |
| 2021-07-07 | Credit Suisse | Initiate | |
| 2021-07-05 | Jefferies | Initiate | |
| 2021-05-13 | JPMorgan Chase | Initiate | Buy |
| 2021-05-13 | Credit Suisse | Initiate | Buy |
| 2021-05-12 | Deutsche Bank | Initiate | Buy |
| 2021-04-22 | Deutsche Bank | Initiate | Buy |
| 2021-04-09 | Credit Suisse | Initiate | Buy |
| 2021-03-18 | Societe Generale | Initiate | Buy |
| 2021-03-16 | JPMorgan Chase | Initiate | Buy |
| 2021-02-23 | UBS | Initiate | Buy |
| 2021-02-08 | Kepler Cheuvreux | Initiate | Neutral |
| 2021-02-08 | Deutsche Bank | Initiate | Neutral |
| 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | ||
|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 16.507B 6.70% | 17.619B 6.74% | 18.489B 4.94% | 19.176B 3.72% | 20.195B 5.31% | 21.171B 4.83% | 22.036B 4.09% | 22.923B 4.03% | |
| EBITDA YoY % growth | 1.176B 18.91% | 1.332B 13.27% | 1.535B 15.24% | 1.761B 14.72% | 1.97B 11.87% | 2.13B 8.12% | 2.132B 0.09% | 2.387B 11.96% | |
| EBIT YoY % growth | 290M 156.64% | 496M 71.03% | 661M 33.27% | 1.153B 74.43% | 1.367B 18.56% | 1.574B 15.14% | 1.735B 10.23% | 1.891B 8.99% | |
| Operating Margin | 1.76% | 2.82% | 3.58% | 6.01% | 6.77% | 7.43% | 7.87% | 8.25% | |
| EPS YoY % growth | 0.73 267.40% | N/A 47.78% | N/A 32.12% | 1.79 26.58% | 2.19 21.78% | 2.44 11.76% | 2.39 -2.12% | N/A |
All data in EUR
| Q4 / 26 | Q2 / 27 | Q4 / 27 | |
|---|---|---|---|
| EPS Q2Q % growth | 0.72 21.54% | 0.76 167.86% | 0.89 23.94% |
| Revenue Q2Q % growth | 9.93B 2.22% | 9.854B 8.78% | 10.602B 6.77% |
| EBITDA Q2Q % growth | N/A | N/A | N/A |
| EBIT Q2Q % growth | 735.92M 83.98% | 713.62M 102.16% | 803.6M 9.20% |
All data in EUR
22 analysts have analysed AOMD.DE and the average price target is 26.51 EUR. This implies a price increase of 13.89% is expected in the next year compared to the current price of 23.28.
ALSTOM (AOMD.DE) will report earnings on 2026-05-13, after the market close.
The consensus EPS estimate for the next earnings of ALSTOM (AOMD.DE) is 0.72 EUR and the consensus revenue estimate is 9.93B EUR.
The number of analysts covering ALSTOM (AOMD.DE) is 22.